Literature DB >> 14278646

TREATMENT OF SALMONELLA CARRIERS WITH COLISTIN SULFATE.

S P GOTOFF, M H LEPPER, M A FIEDLER.   

Abstract

Keywords:  BLOOD UREA NITROGEN; CARRIER STATE; CHLORAMPHENICOL; COLISTIN; DRUG THERAPY; FECES; GERIATRICS; NURSING HOMES; SALMONELLA INFECTIONS

Mesh:

Substances:

Year:  1965        PMID: 14278646     DOI: 10.1097/00000441-196504000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  7 in total

1.  Enterobacteriaceae suppression by three different oral doses of polymyxin E in human volunteers.

Authors:  J J van Saene; H K van Saene; N J Tarko-Smit; G J Beukeveld
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

Review 2.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1966-04       Impact factor: 2.401

3.  Binding to faeces and influence on human anaerobes of antimicrobial agents used for selective decontamination.

Authors:  M P Hazenberg; M Van de Boom; M Bakker; J P Van de Merwe
Journal:  Antonie Van Leeuwenhoek       Date:  1983-06       Impact factor: 2.271

4.  Binding to and antibacterial effect of ampicillin, neomycin and polymyxin B on human faeces.

Authors:  M P Hazenberg; A M Pennock-Schröder; M Van den Boom; J P Van de Merwe
Journal:  J Hyg (Lond)       Date:  1984-08

Review 5.  Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth.

Authors:  Luciano Silvestri; Miguel A de la Cal; Hendrick K F van Saene
Journal:  Intensive Care Med       Date:  2012-09-22       Impact factor: 17.440

6.  Susceptibility of salmonellae to cephalosporins and to nine other antimicrobial agents.

Authors:  R Adams; J D Nelson
Journal:  Appl Microbiol       Date:  1968-10

7.  Selective decontamination and the anaerobic faecal flora.

Authors:  M P Hazenberg; A M Pennock-Schröder
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.